Literature DB >> 9072442

Synergistic effects of Bay K 8644 and bradykinin on norepinephrine release in the hypothalamus of spontaneously hypertensive rats.

K Tsuda1, S Tsuda, I Nishio, Y Masuyama, M Goldstein.   

Abstract

1. In the present study, we examined the effects of Bay K 8644, a dihydropyridine (DHP)-sensitive Ca2+ channel agonist, and bradykinin on norepinephrine release in the hypothalamus of spontaneously hypertensive rats (SHR). 2. In the preliminary studies using Sprague-Dawley rats, Bay K 8644 by itself had no significant effects on the stimulation-evoked [3H]-norepinephrine release from hypothalamic slices. Bradykinin increased the stimulation-evoked [3H]-norepinephrine release in a dose-related fashion. The facilitatory effects of bradykinin on norepinephrine release were potentiated by Bay K 8644. 3. In SHR, Bay K 8644 significantly increased the stimulation-evoked norepinephrine release from hypothalamic slices. However, exposure of slices to Bay K 8644 caused no significant effects on norepinephrine release in Wistar-Kyoto (WKY) rats. The effects of Bay K 8644 in combination with bradykinin on the stimulation-evoked norepinephrine release were also greater in SHR than in WKY rats. 4. These results demonstrate that Bay K 8644 significantly potentiated the facilitatory effects of bradykinin on norepinephrine release in rat hypothalamus. The finding indicates a possible interaction of bradykinin with DHP-sensitive Ca2+ channels in the central nervous system. Furthermore, the pronounced effects of Bay K 8644 and bradykinin in SHR suggest that bradykinin-related Ca2+ channels might have a role in the regulation of norepinephrine release in the hypothalamus of SHR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9072442     DOI: 10.1111/j.1440-1681.1995.tb02968.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol Suppl        ISSN: 0143-9294


  3 in total

1.  Serine-727 phosphorylation activates hypothalamic STAT-3 independently from tyrosine-705 phosphorylation.

Authors:  Andreas Breit; Valeria Besik; Hans Jürgen Solinski; Susanne Muehlich; Evi Glas; Stephen J Yarwood; Thomas Gudermann
Journal:  Mol Endocrinol       Date:  2015-01-13

2.  Endostatin inhibits bradykinin-induced cardiac contraction.

Authors:  Jumpei Yasuda; Lila Takada; Yuka Kajiwara; Muneyosi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2015-06-05       Impact factor: 1.267

3.  Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.

Authors:  Kazushi Tsuda
Journal:  Int J Hypertens       Date:  2012-11-21       Impact factor: 2.420

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.